Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma

博士 === 國立陽明大學 === 分子醫學博士學位學程 === 107

Bibliographic Details
Main Authors:	Roger Shen, 沈宗傑
Other Authors:	Yuh-Shan Jou
Format:	Others
Language:	en_US
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/z5suft

id	ndltd-TW-107YM005538009
record_format	oai_dc
spelling	ndltd-TW-107YM0055380092019-11-12T05:21:19Z http://ndltd.ncl.edu.tw/handle/z5suft Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma 異常核表現之SLC29A2作為肝癌治療標的之機轉與開發 Roger Shen 沈宗傑博士國立陽明大學分子醫學博士學位學程 107 Yuh-Shan Jou 周玉山 2019 學位論文 ; thesis 67 en_US
collection	NDLTD
language	en_US
format	Others
sources	NDLTD
description	博士 === 國立陽明大學 === 分子醫學博士學位學程 === 107
author2	Yuh-Shan Jou
author_facet	Yuh-Shan Jou Roger Shen 沈宗傑
author	Roger Shen 沈宗傑
spellingShingle	Roger Shen 沈宗傑 Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma
author_sort	Roger Shen
title	Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma
title_short	Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma
title_full	Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma
title_fullStr	Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma
title_full_unstemmed	Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma
title_sort	aberrant nuclear-expressed slc29a2 as a therapeutic target in hepatocellular carcinoma
publishDate	2019
url	http://ndltd.ncl.edu.tw/handle/z5suft
work_keys_str_mv	AT rogershen aberrantnuclearexpressedslc29a2asatherapeutictargetinhepatocellularcarcinoma AT chénzōngjié aberrantnuclearexpressedslc29a2asatherapeutictargetinhepatocellularcarcinoma AT rogershen yìchánghébiǎoxiànzhīslc29a2zuòwèigānáizhìliáobiāodezhījīzhuǎnyǔkāifā AT chénzōngjié yìchánghébiǎoxiànzhīslc29a2zuòwèigānáizhìliáobiāodezhījīzhuǎnyǔkāifā
_version_	1719290052879581184

Aberrant nuclear-expressed SLC29A2 as a therapeutic target in hepatocellular carcinoma

Similar Items